ClearPoint Neuro, Inc. (CLPT)
7.31
-0.40
(-5.19%)
USD |
NASDAQ |
Nov 19, 16:00
7.31
0.00 (0.00%)
After-Hours: 20:00
ClearPoint Neuro Enterprise Value : 261.81M for Nov. 19, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 261.81M |
| November 18, 2026 | 274.63M |
| November 17, 2026 | 279.44M |
| November 16, 2026 | 293.54M |
| November 13, 2026 | 299.31M |
| November 12, 2026 | 299.63M |
| November 11, 2026 | 321.43M |
| November 10, 2026 | 308.61M |
| November 09, 2026 | 321.43M |
| November 06, 2026 | 303.16M |
| November 05, 2026 | 306.04M |
| November 04, 2026 | 353.16M |
| November 03, 2026 | 338.74M |
| November 02, 2026 | 346.43M |
| October 30, 2026 | 369.50M |
| October 29, 2026 | 370.15M |
| October 28, 2026 | 365.98M |
| October 27, 2026 | 338.09M |
| October 26, 2026 | 317.26M |
| October 23, 2026 | 320.47M |
| October 22, 2026 | 323.99M |
| October 21, 2026 | 323.99M |
| October 20, 2026 | 330.40M |
| October 19, 2026 | 321.43M |
| October 16, 2026 | 318.22M |
| Date | Value |
|---|---|
| October 15, 2026 | 336.49M |
| October 14, 2026 | 323.67M |
| October 13, 2026 | 341.94M |
| October 12, 2026 | 354.44M |
| October 09, 2026 | 363.41M |
| October 08, 2026 | 363.74M |
| October 07, 2026 | 369.18M |
| October 06, 2026 | 380.40M |
| October 05, 2026 | 396.75M |
| October 02, 2026 | 376.72M |
| October 01, 2026 | 394.50M |
| September 30, 2026 | 418.86M |
| September 29, 2026 | 393.60M |
| September 28, 2026 | 501.59M |
| September 25, 2026 | 486.94M |
| September 24, 2026 | 480.23M |
| September 23, 2026 | 491.21M |
| September 22, 2026 | 516.23M |
| September 21, 2026 | 460.71M |
| September 18, 2026 | 456.44M |
| September 17, 2026 | 453.70M |
| September 16, 2026 | 443.32M |
| September 15, 2026 | 435.70M |
| September 14, 2026 | 445.15M |
| September 11, 2026 | 453.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 207.35B |
| AngioDynamics, Inc. | 433.25M |
| Alphatec Holdings, Inc. | 1.596B |
| AtriCure, Inc. | 2.665B |
| Baxter International, Inc. | 19.15B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.46M |
| Revenue (Quarterly) | 12.08M |
| Total Expenses (Quarterly) | 19.54M |
| EPS Diluted (Quarterly) | -0.2408 |
| Gross Profit Margin (Quarterly) | 56.75% |
| Profit Margin (Quarterly) | -61.78% |
| Earnings Yield | -16.56% |
| Normalized Earnings Yield | -16.56 |